Signet invests in CRDMO Laxai
Laxai operates a drug substance manufacturing facility in Hyderabad.
24 October 2022•1 min read
Laxai operates a drug substance manufacturing facility in Hyderabad.
New Mountain’s Grant Thornton Advisors closes $5bn take-private of CBIZ
18 minutes ago · 2 mins read
Interlock Equity seals $525m sale of Lovelytics to CDW
28 minutes ago · 2 mins read
Accel-KKR’s VisiQuate buys Finvi’s Artiva HCx revenue cycle business
39 minutes ago · 2 mins read
May River Capital agrees to $675m sale of Parameter Technologies to Acuity
40 minutes ago · 1 min read
Onyx Partners strikes two-phase deal for Florida retailer Kane’s Furniture
1 hour ago · 1 min read
Kester-backed Evestia Clinical acquires Belgian medical writing firm Emtex in third add-on
1 hour ago · 1 min read
Weatherford Capital invests in Arnold Palmer Junior Golf Tour alongside Bolt Ventures
1 hour ago · 2 mins read
